Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells

= .048). We did not find evidence that steroid use ≥7 days altered the patient's outcome when compared with <7 days of steroids. Management of CAR T cell-mediated neurotoxicity warrants evaluation in prospective clinical trials.